Interferences with urine drug screens.

Published

Journal Article (Review)

Qualitative urine drug assays are frequently used in conjunction with opioid contracts as a means of monitoring use of prescribed controlled substances as well as concurrent use of illicit substances in patients receiving opioids for chronic nonmalignant pain (CNMP) management. Appropriate use of these screening tests, in conjunction with opioid contracts, may provide the health care provider with additional information needed to safely prescribe opioids for selected individuals with CNMP. It is important for the practitioner caring for patients subject to random urine drug screening to understand interferences with the commonly used urine drug assays, as well as knowing options to confirm contested test results. We reviewed the literature on urine drug assay test interferences and present a summary of this information in this article.

Full Text

Duke Authors

Cited Authors

  • Herring, C; Muzyk, AJ; Johnston, C

Published Date

  • February 2011

Published In

Volume / Issue

  • 24 / 1

Start / End Page

  • 102 - 108

PubMed ID

  • 21507878

Pubmed Central ID

  • 21507878

Electronic International Standard Serial Number (EISSN)

  • 1531-1937

International Standard Serial Number (ISSN)

  • 0897-1900

Digital Object Identifier (DOI)

  • 10.1177/0897190010380463

Language

  • eng